$PG - Charting is Therapeutic

35
PG forming solid base at $159 support after 15% pullback from Feb highs.

Strong fundamentals intact with 19% profit margins in Q3. Recent analyst actions positive RBC upgraded to BUY in April, Evercore just raised PT to $190 (19% upside).

Defensive consumer staple with reliable dividend (65% payout ratio). Patient investors rewarded here. #ValueInvestment #Dividends

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。